Targeting NRF2 Sensitizes Esophageal Adenocarcinoma Cells to Cisplatin through Induction of Ferroptosis and Apoptosis.

MLA

Ballout, Farah, et al. “Targeting NRF2 Sensitizes Esophageal Adenocarcinoma Cells to Cisplatin through Induction of Ferroptosis and Apoptosis.” Antioxidants, vol. 11, no. 10, Oct. 2022, p. N.PAG. EBSCOhost, https://doi.org/10.3390/antiox11101859.

APA

Ballout, F., Lu, H., Chen, Z., Hu, T., Chen, L., Washington, M. K., El-Rifai, W., & Peng, D. (2022). Targeting NRF2 Sensitizes Esophageal Adenocarcinoma Cells to Cisplatin through Induction of Ferroptosis and Apoptosis. Antioxidants, 11(10), N.PAG. https://doi.org/10.3390/antiox11101859

Chicago

Ballout, Farah, Heng Lu, Zheng Chen, Tianling Hu, Lei Chen, Mary Kay Washington, Wael El-Rifai, and Dunfa Peng. 2022. “Targeting NRF2 Sensitizes Esophageal Adenocarcinoma Cells to Cisplatin through Induction of Ferroptosis and Apoptosis.” Antioxidants 11 (10): N.PAG. doi:10.3390/antiox11101859.